Raya Mawad

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

Bijal Shah, Michael R. Bishop, Olalekan O. Oluwole et al. · Blood · 2021 · 190 citations · Full text

Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of Vibecotamab (XmAb14045), a CD123 x CD3 T Cell-Engaging Bispecific Antibody; Initial Results of a Phase 1 Study

Farhad Ravandi, Asad Bashey, Wendy Stock et al. · Blood · 2020 · 68 citations

Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Raya Mawad, Ted Gooley, Joseph G. Rajendran et al. · Biology of Blood and Marrow Transplantation · 2014 · 65 citations · Full text

Mixed-phenotype Acute Leukemia, Younger Patients, Immunology +21

Central Nervous System Relapse in Adults with Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Amir Hamdi, Raya Mawad, Roland L. Bassett et al. · Biology of Blood and Marrow Transplantation · 2014 · 56 citations · Full text

Cell Therapy, Immunology, Cell Replacement Therapy +17

Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of XmAb14045, a CD123 x CD3 T Cell-Engaging Bispecific Antibody: Initial Results of a Phase 1 Study

Farhad Ravandi, Asad Bashey, James M. Foran et al. · Blood · 2018 · 56 citations